Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Tian'an Biopharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale production of diabetes treatments, particularly insulin products. As a subsidiary of China Meheco Co., Ltd., the company operates a significant manufacturing base in the Liaoning (Benxi) Bio-pharmaceutical Industry High-tech Zone. Its product portfolio includes recombinant human insulin injections and various oral hypoglycemic agents. The company is recognized for its integrated capabilities in fermentation, purification, and finished dosage form manufacturing. Liaoning Tian'an Biopharmaceutical plays a key role in the domestic Chinese supply chain for affordable diabetes management solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Tian'an Biopharmaceutical.